Dapagliflozin in Systemic Right Ventricle (DAPA-SERVE)

Clinical trial NCT05717257 · UNKNOWN

Trial details

NCT number: NCT05717257
Sponsor: Monaldi Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Dapagliflozin Adverse Reaction Efficacy Systemic Right Ventricle

Start date: 2022-08-01
Primary completion: 2023-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.